News

A team of researchers has identified the gene that, when mutated, causes a devastating early-onset disorder in babies known as “malignant migrating partial seizures of infants,” or MMPSI.

Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.

TriLink announced that it has awarded Dr. Tony Yan of Brock University a ResearchReward for CleanAmp™ PCR reagents, nucleoside triphosphates and oligonucleotides.

B-SMART™ technology will be used to develop rapid tuberculosis antimicrobial susceptibility test.

Over the last decade an ENU mutagenesis program was operated by the Beutler laboratory at The Scripps Research Institute in La Jolla, CA.

Companies have entered into a co-promotion agreement, enabling them to promote each other’s products.

Regarding that MZ twins are identical in genetic composition, the IQ difference could be associated with environmental factors, via epigenetic mechanisms regulations.

The 13485:2003 certification are for Design, Development and Manufacturing of IVD Medical Devices for Detection of Infectious Diseases; and Manufacturing of Oligonucleotides and Sequencing Services.

Takara Bio Inc. (Japan) announced that it has entered into a distribution agreement with Exiqon A/S (Denmark) and will start to market its miRCURY LNA™ products from January 7, 2013.

Soricimed Biopharma Inc. announced that a pre-regulatory study of their blood test for early detection and diagnosis of cancer has commenced.